Literature DB >> 15661228

Lymph node metastases in low-grade endometrial stromal sarcoma.

J Riopel1, M Plante, M-C Renaud, M Roy, B Têtu.   

Abstract

OBJECTIVES: The objective of this study was to review our experience on lymphatic dissemination in patients with low-grade endometrial stromal sarcoma.
METHODS: All cases diagnosed as low-grade endometrial stromal sarcoma or endolymphatic stromal myosis before October 2003 and who had lymph node sampling at some point in their evolution were retrieved from the files of the pathology and gynecologic oncology departments of l'Hotel-Dieu de Quebec University Hospital (HDQ).
RESULTS: Fifteen patients with either limited lymph node biopsies or a complete lymph node dissection at some point in the course of their disease were found. Five of these patients (33%) presented lymph node metastases either at the initial hysterectomy, during a subsequent staging procedure, or at the time of a recurrence.
CONCLUSION: These findings suggest that the incidence of lymph node involvement in low-grade endometrial stromal sarcoma is higher than expected. More extensive sampling of lymph nodes in a larger number of patients may allow a better understanding of the frequency and prognostic significance of these metastases.

Entities:  

Mesh:

Year:  2005        PMID: 15661228     DOI: 10.1016/j.ygyno.2004.10.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

1.  Intravenous low-grade endometrial stromal sarcoma with intracardiac extension: A CASE OF inaccurate tumor location on contrast-enhanced computed tomography.

Authors:  Yuya Nogami; Wataru Yamagami; Junko Maki; Kouji Banno; Nobuyuki Susumu; Koichi Tomita; Kentaro Matsubara; Hideaki Obara; Yuko Kitagawa; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2015-12-02

Review 2.  Current and future options in the management and treatment of uterine sarcoma.

Authors:  Khalid El-Khalfaoui; Andreas du Bois; Florian Heitz; Christian Kurzeder; Jalid Sehouli; Philipp Harter
Journal:  Ther Adv Med Oncol       Date:  2014-01       Impact factor: 8.168

Review 3.  Current management of uterine sarcomas.

Authors:  Elena García-Martínez; Lucas Egea Prefasi; Jesús García-Donas; Pedro Pablo Escolar-Pérez; Francisco Pastor; Antonio González-Martín
Journal:  Clin Transl Oncol       Date:  2011-05       Impact factor: 3.405

Review 4.  [Metastatic mechanisms of uterine malignancies and therapeutic consequences].

Authors:  S F Lax; K F Tamussino; P F Lang
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

5.  [Uterine sarcoma treatment].

Authors:  G Köhler
Journal:  Pathologe       Date:  2009-07       Impact factor: 1.011

6.  Recurrent endometrial stromal sarcoma: treatment with a progestin and gonadotropin releasing hormone agonist.

Authors:  Nefertiti Chianti Dupont; Philip John Disaia
Journal:  Sarcoma       Date:  2010-06-10

7.  Endometrial stromal sarcomas: a retrospective analysis of 28 patients, single center experience for 20 years.

Authors:  Eun Ji Nam; Jae Wook Kim; Dae Woo Lee; Si Young Jang; Jong Wook Hong; Young Tae Kim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim
Journal:  Cancer Res Treat       Date:  2008-03-31       Impact factor: 4.679

8.  Endometrial stromal sarcoma: A review of the literature.

Authors:  Geetha Puliyath; M Krishnan Nair
Journal:  Indian J Med Paediatr Oncol       Date:  2012-01

Review 9.  Treatment of early uterine sarcomas: disentangling adjuvant modalities.

Authors:  Flora Zagouri; Athanasios-Meletios Dimopoulos; Stelios Fotiou; Vassilios Kouloulias; Christos A Papadimitriou
Journal:  World J Surg Oncol       Date:  2009-04-08       Impact factor: 2.754

10.  A case of endometrial stromal sarcoma with synchronous bilateral adenocarcinoma of ovary.

Authors:  Olga Caramelo; Carol Marinho; Teresa Rebelo; Natália Amaral; Fernando Mota; Fernanda Xavier da Cunha; Isabel Torgal
Journal:  Case Rep Obstet Gynecol       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.